Number of Shares
402,875.00
Current Holdings Value*
$1.41 Mil
% of Portfolio
5.3%
Total Estimate Gain
$144,648.44
% of Total Estimate Gain
9.96%

Global Endurance Portfolio's Arbutus Biopharma Corp Holding Summary

As of 2025-03-31, MORGAN STANLEY INSTITUTIONAL FUND INC held 402,875.00 shares of Arbutus Biopharma Corp(ABUS), totaling $1.41 Mil. This investment constitutes 5.3% of their stock portfolio, and MORGAN STANLEY INSTITUTIONAL FUND INC now holds 0.21% of the outstanding Arbutus Biopharma Corp(ABUS) stock.

The initial trade took place in 2023Q1. And since then Global Endurance Portfolio has made 5 purchases of ABUS, at an average price of $3.01, for a total of 483,183.00 shares. In addition, there have been 2 sales at an average price of $3.69 for 80,308.00 shares. Based on historical transaction data and ABUS's current price of $3.23, Global Endurance Portfolio's estimated gain on his ABUS holdings is $144,648.44, reflecting a 9.96% gain to date.

Global Endurance Portfolio ABUS ($3.23) Holding Chart

Global Endurance Portfolio ABUS ($3.23) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1